Try our Advanced Search for more refined results
January 10, 2023
FENNEC PHARMACEUTICALS, INC. et al
Case Number:
3:23-cv-00123
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 11, 2023
Fennec Sues Cipla Over Generic Hearing Loss Treatment Bid
Biotechnology company Fennec Pharmaceuticals and an Oregon university have accused an Indian company of infringing a trio of patents on a therapy to treat hearing loss in children undergoing chemotherapy.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login